Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Hidradenitis Suppurativa Q&As

Dr Amit Garg: Comorbidity Screening in HS
Q&As
Dr Amit Garg: Comorbidity Screening in HS
05/19/2021
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights...
05/19/2021
The Dermatologist
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
Q&As
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
04/24/2021
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD...
04/24/2021
The Dermatologist
The Who and When of Intralesional Injections for HS Treatment
Q&As
The Who and When of Intralesional Injections for HS Treatment
03/26/2021
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met...
03/26/2021
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

FDA Alerts
FDA Approves Moderate to Severe Plaque Psoriasis Treatment
02/16/2017
The FDA approved the injectable biologic, brodalumab (Siliq, Valeant Pharmaceuticals) to treat adults with moderate to severe psoriasis. Brodalumab is indicated for patients who are candidates for systemic treatment or phototherapy who have...
The FDA approved the injectable biologic, brodalumab (Siliq, Valeant Pharmaceuticals) to treat adults with moderate to severe psoriasis. Brodalumab is indicated for patients who are candidates for systemic treatment or phototherapy who have...
The FDA approved the injectable...
02/16/2017
The Dermatologist
Resident Journal Club
Treating Pemphigus Vulgaris; Cutaneous Melanoma In Situ; and "Addictive" Properties of Tanning
02/18/2014
This online-only feature will be an ongoing review and discussion of past articles that have had a significant impact on dermatology and that every dermatologist should read.     Casey E. Watkins, MD Treating pemphigus...
This online-only feature will be an ongoing review and discussion of past articles that have had a significant impact on dermatology and that every dermatologist should read.     Casey E. Watkins, MD Treating pemphigus...
This online-only feature will be...
02/18/2014
The Dermatologist
News
Patients With Psoriasis Tend To Exercise Less
01/10/2017
Patients with psoriasis are less likely to use exercise to lose weight compared to patients without psoriasis, according to a recent study.
Patients with psoriasis are less likely to use exercise to lose weight compared to patients without psoriasis, according to a recent study.
Patients with psoriasis are less...
01/10/2017
The Dermatologist
NAAF President & CEO To Retire
11/12/2013
Long-time leader of the National Alopecia Areata Foundation (NAAF), President and CEO Vicki Kalabokes will retire on March 31, 2014. As of February 1, 2014, Kalabokes has helmed the foundation for 27 years and has brought the NAAF from a...
Long-time leader of the National Alopecia Areata Foundation (NAAF), President and CEO Vicki Kalabokes will retire on March 31, 2014. As of February 1, 2014, Kalabokes has helmed the foundation for 27 years and has brought the NAAF from a...
Long-time leader of the National...
11/12/2013
The Dermatologist
U.S. FDA Outlines Data Needed For Over-The-Counter Sunscreen Additives
11/23/2016
The FDA recently issued guidelines detailing the data makers of sunscreen that are sold over the counter, need to produce to prove the ingredients in the products are safe and effective.
The FDA recently issued guidelines detailing the data makers of sunscreen that are sold over the counter, need to produce to prove the ingredients in the products are safe and effective.
The FDA recently issued...
11/23/2016
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
Riya Gandhi, MA, Associate Editor
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA, Associate Editor
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA, Associate Editor
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA, Associate Editor
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
Jessica Garlewicz, Digital Managing Editor
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use